Emirates Drug Establishment Enforces Strict Approval Process for Medical Product Advertisements

Dubai:The Emirates Drug Establishment (EDE) recently held a Customer Council at Emirates Towers, focusing on the critical need for prior approval before publishing or circulating medical product advertisements. The event gathered partners, customers, and industry representatives to discuss regulatory updates and compliance requirements.

According to Emirates News Agency, the council took place at the Government Accelerators Centre and aimed to inform stakeholders about the latest regulations governing promotional content. Key topics included the introduction of advertising for Prescription-Only Medicines (POMs) under approved regulatory controls and the various advertising channels such as print, audio, visual materials, websites, and social media platforms.

The event also addressed the advertisement licensing system, detailing the application process, necessary documents, and content requirements. Discussions emphasized the importance of accurate and clear advertising content, ensuring consistency with approved product information and highlighting potential risks or side effects.

Participants explored the necessity of appropriate disclaimers based on the product and audience while stressing the prohibition of self-diagnosis or self-prescription without healthcare professional oversight. The council highlighted the mechanisms for handling non-compliant content and coordination with authorities to enforce regulations, including the ban on social media influencers promoting medical products.

The meeting provided an interactive platform for customers to share their experiences and suggestions, with a focus on clarifying procedures and improving the application process. This initiative is part of EDE's efforts to engage stakeholders, enhance service development, and promote safe medical product use.